• Fund Type: SICAV
  • Objective: Global Allocation
  • Asset Class: Mixed Allocation
  • Geographic Focus: Global

Nimbus 2002 SICAV SA

+ Add to Watchlist

S2231:SM

7.7700 EUR 0.00000.00%

As of 11:39:01 ET on 11/26/2014.

Snapshot for Nimbus 2002 SICAV SA (S2231)

Open: - High - Low: - Primary Exchange: Soc.Bol SIBE
Volume: 5 52-Week Range: 7.4200 - 8.1100 Beta vs IBEX: 0.4052

ETF Chart for S2231

No chart data available.
  • S2231:SM 7.7700
  • 1M
  • 1Y
7.7700
Interactive S2231 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for S2231

Nimbus 2002 SICAV SA is an open-end investment company incorporated in Spain. The investment company's objective is capital growth. It primarily invests in equity securities.

Inception Date: 2007-05-29 Telephone: 34-902-100-500
Managers: -
Web Site: www.popularbancaprivada.es

Fundamentals for S2231

NAV (on 2014-11-25) 7.7657
Assets (M) (on 2013-04-04) 3.8817
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium 0.18
Average 52-Week % Premium -0.0101
Fund Leveraged N

Dividends for S2231

No dividends reported

Performance for S2231

1-Month +0.26% 1-Year +1.44%
3-Month -3.36% 3-Year +1.05%
Year To Date -0.89% 5-Year -3.11%
Expense Ratio -

Top Fund Holdings for S2231

Filing Date: 09/30/2014
Name Position Value % of Total
SPGB 5 ½ 07/30/17 2,175 2,175,000 47.635%
SAP SE 3,990 228,000 4.993%
Bayer AG 2,005 222,000 4.862%
Amgen Inc 2,004 222,000 4.862%
Statoil ASA 10,131 216,000 4.731%
EI du Pont de Nemours & Co 3,012 170,000 3.723%
Johnson & Johnson 2,015 169,000 3.701%
GlaxoSmithKline PLC 8,098 145,000 3.176%
Merck & Co Inc 3,004 141,000 3.088%
Allianz SE 997 128,000 2.803%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil